Nesyrgy (Amlodipine Besilate, Nebivolol Hydrochloride)

Amlodipine blocks calcium entry into vascular smooth muscle, causing vasodilation, while nebivolol selectively blocks β1‑adrenergic receptors and enhances nitric‑oxide release. Together they reduce peripheral resistance and heart rate, producing an additive blood‑pressure‑lowering effect.

The appropriate dose of Nesyrgy is determined by the prescribing clinician based on the individual’s blood‑pressure profile, age, renal and hepatic function, and tolerance. Patients should follow the specific dosing instructions provided by their healthcare professional.

Safety of Nesyrgy during pregnancy or lactation has not been fully established. It should be used only if the potential benefit justifies the potential risk to the fetus or infant, and only under direct medical supervision.

To order Nesyrgy, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with monotherapy using either amlodipine or nebivolol alone, the combination offers complementary mechanisms—vascular dilation and heart‑rate reduction—potentially achieving better blood‑pressure control with a single tablet. It may reduce the need for multiple separate agents, but individual response varies.

Nesyrgy tablets should be stored at below 25 °C in a dry place. Keep them in the original container, protect from moisture and direct sunlight, and keep out of reach of children.

Nesyrgy is taken orally as a tablet. Swallow the tablet whole with a glass of water, with or without food, as directed by the prescribing clinician.

Serious adverse events include severe hypotension, marked bradycardia, heart block, and angioedema. Patients should seek immediate medical attention if they experience fainting, rapid heartbeat, swelling of the face or throat, or any signs of an allergic reaction.

Nesyrgy is contraindicated in patients with severe hypotension, cardiogenic shock, advanced atrioventricular block, or known hypersensitivity to amlodipine, nebivolol or any excipients. Clinicians should also avoid use in patients with uncontrolled heart failure without careful monitoring.